CD44 and breast carcinoma: MeCSC subpopulations such as CD44v6 CSCs or CD26+ CSCs in colorectal cancer [47, 48], CD44+ CSCs in breast cancer [49], and CXCR4+ CSCs in prostate cancer [50] have also been found.